XALACOM

This brand name is authorized in Austria, Australia, Brazil, Canada, Germany, Ecuador, Estonia, Spain, France, Hong Kong, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Mexico, Nigeria, Netherlands, Poland, Singapore, Tunisia, Turkey, United Kingdom, South Africa

Active ingredients

The drug XALACOM contains a combination of these active pharmaceutical ingredients (APIs):

1 Latanoprost UNII 6Z5B6HVF6O - LATANOPROST

The active substance latanoprost, a prostaglandin F2α analogue, is a selective prostanoid FP receptor agonist which reduces the intraocular pressure (IOP) by increasing the outflow of aqueous humour. Reduction of the IOP in man starts about three to four hours after administration and maximum effect is reached after eight to twelve hours. Read about Latanoprost

2 Timolol UNII P8Y54F701R - TIMOLOL MALEATE

Timolol is a non-selective beta-adrenergic receptor blocking agent that does not have significant intrinsic sympathomimetic, direct myocardial depressant, or local anaesthetic activity. Timolol reduces intra-ocular pressure, whether or not this is associated with glaucoma. Read about Timolol

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
S01ED51	Timolol, combinations	S Sensory organs → S01 Ophthalmologicals → S01E Antiglaucoma preparations and miotics → S01ED Beta blocking agents
Discover more medicines within S01ED51

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 5553G, 8895E
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 552820060069317
Country: CA	Health Products and Food Branch	Identifier(s): 02246619
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 00417220, 00417237, 01246588, 01246594, 01246648, 02140107, 02140142, 02725351, 02725368, 02725374, 03259394, 03420010, 09542895, 09542903, 10418166, 13743955, 13749449, 13749455, 13824955, 13832541, 15266399, 16698155
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 29525-12-10
Country: EE	Ravimiamet	Identifier(s): 1088254, 1393062
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 64187
Country: FR	Base de données publique des médicaments	Identifier(s): 63781007
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 139796, 147621, 164560, 36431, 374017, 377100
Country: HK	Department of Health Drug Office	Identifier(s): 49378
Country: IE	Health Products Regulatory Authority	Identifier(s): 53908, 73590
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 4591
Country: IT	Agenzia del Farmaco	Identifier(s): 035402015
Country: JP	医薬品医療機器総合機構	Identifier(s): 1319817Q1020
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1003991
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 368M2001
Country: NG	Registered Drug Product Database	Identifier(s): A4-2253
Country: NL	Z-Index G-Standaard	Identifier(s): 14696037
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 60526
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100122906
Country: SG	Health Sciences Authority	Identifier(s): 11922P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 4133011, 4133012
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699532618368
Country: ZA	Health Products Regulatory Authority	Identifier(s): 36/15.4/0043